The biological characteristics of CD34+ CD2+ adult acute promyelocytic leukemia and the CD34- CD2- hypergranular (M3) and microgranular (M3v) phenotypes

Haematologica

Volumn 91, Issue 3, 2006, Pages 311-316

  Albano, Francesco ^a   Mestice, Anna ^a   Pannunzio, Alessandra ^a   Lanza, Francesco ^b   Martino, Bruno ^c   Pastore, Domenico ^a   Ferrara, Felicetto ^d   Carluccio, Paola ^a   Nobile, Francesco ^c   Castoldi, Gianluigi ^b   Liso, Vincenzo ^a   Specchia, Giorgina ^a  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c BIANCHI MELACRINO MORELLI HOSPITAL   (Italy)

^d CARDARELLI HOSPITAL   (Italy)

Author keywords

Acute promyelocytic leukemia; CD2; CD34; Immunophenotype

Indexed keywords

CD15 ANTIGEN; CD2 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; HEMOGLOBIN; HLA DR ANTIGEN; PROMYELOCYTIC LEUKEMIA PROTEIN;

ADULT; AGED; ARTICLE; BIOLOGICAL TRAIT; CONTROLLED STUDY; FEMALE; GRANULAR CELL; HUMAN; IMMUNOPHENOTYPING; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PROMYELOCYTIC LEUKEMIA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REMISSION; SURVIVAL; THROMBOCYTE COUNT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD2; ANTIGENS, CD34; FEMALE; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PHENOTYPE; VARIATION (GENETICS);

EID: 33645387266     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) cooperative group. Br J Haematol 1976;33:451-8.
2. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR, et al. Variant form of hypergranular promyelocytic leukaemia (M3). Br J Haematol 1980;44:169-70.
3. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group. Ann Intern Med 1985;103:620-5.
4. Liso V, Bennett JM. Morphological and cytochemical characteristics of leukaemic promyelocytes. Best Pract Res Clin Haematol 2003;16:349-55.
5. Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, et al. Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukaemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease. Blood 2002;100:59-66.
6. Haferlach T, Kohlmann A, Schnittger S, Dugas M, Hiddemann W, Kern W, et al. AML M3 and AML M3 variant each have a distinct gene expression signature but also share patterns different from other genetically defined AML subtypes. Genes Chromosomes Cancer 2005;43:113-27.
7. Noguera NI, Breccia M, Divona M, Diverio D, Costa V, De Santis S, et al. Alterations of the FLT3 gene in acute promyelocytic leukaemia: association with diagnostic characteristics and analysis or clinical outcome in patients treated with the Italian AIDA protocol. Leukemia 2002;16:2185-9.
8. San Miguel JF, Gonzalez M, Canizo MC, Anta JP, Zola H, Lopez Borrasca A. Surface marker analysis in acute myeloid leukaemia and correlation with FAB classification. Br J Haematol 1986;64:547-60.
9. Foley R, Soamboonsrup P, Carter RF, Benger A, Meyer R, Walker I, et al. CD34-positive acute promyelocytic leukaemia is associated with leukocytosis, microgranular/hypogranular morphology, expression or CD2 and bcr3 isoform. Am J Hematol 2001;67:34-41.
10. Paietta E, Goloubeva O, Bennett JM. A surrogate marker profile for acute promyelocytic leukaemia (APL) and the association of immunophenotypic markers with morphologic and molecular subtypes of APL [abstract]. Blood 2002;100 Suppl 1:229b.
11. Guglielmi C, Martelli MP, Diverio D, Fenu S, Vegna ML, Cantu-Rajnoldi A, et al. Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases. Br J Haematol 1998;102:1035-41.
12. Lee JJ, Cho D, Chung IJ, Cho SH, Park KS, Park MR, et al. CD34 expression is associated with poor clinical outcome in patients with acute promyelocytic leukemia. Am J Hematol 2003;73:149-53.
13. Lin P, Hao S, Medeiros LJ, Estey EH, Pierce SA, Wang X, et al. Expression of CD2 in acute promyelocytic leukemia correlates with short form of PML-RARα transcripts and poorer prognosis. Am J Clin Pathol 2004;121:402-7.
14. 3v) but not with any PML gene breakpoint. Leukemia 1995;9:1461-6.
15. Avvisati G, Lo Coco F, Diverio D, Falda M, Ferrara F, Lazzarino M, et al. AIDA (all-trans retinoic acid+ idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study. Blood 1996;88:1390-8.
16. Avvisati G, Petti MC, Lo Coco F, Vegna ML, Amadori S, Baccarani M, et al. Induction therapy with idarubicin alone significantly influences event-free survival duration in patients with newly diagnosed hypergranular promyelocytic leukemia: final results of the GIMEMA randomized study LAP 0389 with 7 years of minimal follow-up. GIMEMA (Gruppo Italiano Malattie Ematologische dell'Adulto) Italian Cooperative Group. Blood 2002;100:3141-6.
17. Piedras J, Lopez-Karpovitch X, Cardenas R. Light scatter and immunophenotypic characteristics of blast cells in typical acute promyelocytic leukemia and its variant. Cytometry 1998;32:286-90.
18. Cheson BD, Cassileth PA, Head DR, Schiffer CA, Bennett JM, Bloomfield CD, et al. Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia. J Clin Oncol 1990;8:813-9.
19. Smith LJ, Curtis JE, Messner HA, Senn JS, Furthmayr H, McCulloch EA. Lineage infidelity in acute leukemia. Blood 1983;61:1138-45.
20. Greaves MF, Chan LC, Furley AJ, Watt SM, Molgaard HV. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 1986;67:1-11.
21. Miyamoto T, Iwasaki H, Reizis B, Ye M, Graf T, Weissman IL, et al. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Develop Cell 2002;3:137-47.
22. Akashi K, He X, Chen J, Iwasaki H, Niu C, Steenhard B, et al. Transcriptional accessibility for genes of multiple tissues and hematopoietic lineages is hierarchically controlled during early hematopoiesis. Blood 2003;101:383-9.
23. Ferrara F, Morabito F, Martino B, Specchia G, Liso V, Nobile F, et al. CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy. J Clin Oncol 2000;6:1295-300.
24. Callens C, Chevret S, Cayuela JM, Cassinat B, Raffoux E, de Botton S, et al. Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukaemia (APL): a retrospective study from the European APL Group. The European APL Group. Leukemia 2005;19:1153-60.